Abstract:« Previous Next » [1] Klein, B.E. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. , 2007 , 14 (4), 179-183. [http://dx.doi.org/10.1080/09286580701396720] [PMID: 17896294] [2] Mansour, S.E.; Browning, D.J.; Wong, K.; Flynn, H.W., Jr; Bhavsar, A.R. The evolving treatment of diabetic retinopathy. Clin. Ophthalmol. , 2020 , 14 , 653-678. [http://dx.doi.org/10.2147/OPTH.S236637] [PMID: 32184554] [3] Wang, J.H.; Ling, D.; Tu, L.; van Wijngaarden, P.; Dusting, G.J.; Liu, G.S. Gene therapy for diabetic retinopathy: Are we ready to make the leap from bench to bedside? Pharmacol. Ther. , 2017 , 173 , 1-18. [http://dx.doi.org/10.1016/j.pharmthera.2017.01.003] [PMID: 28132907] [4] Simó, R.; Hernández, C. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog. Retin. Eye Res. , 2015 , 48 , 160-180. [http://dx.doi.org/10.1016/j.preteyeres.2015.04.003] [PMID: 25936649] [5] Yan, B.; Tao, Z.F.; Li, X.M.; Zhang, H.; Yao, J.; Jiang, Q. Aberrant expression of long noncoding RNAs in early diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. , 2014 , 55 (2), 941-951. [http://dx.doi.org/10.1167/iovs.13-13221] [PMID: 24436191] [6] Hung, T.; Chang, H.Y. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol. , 2010 , 7 (5), 582-585. [http://dx.doi.org/10.4161/rna.7.5.13216] [PMID: 20930520] [7] Zhang, D.; Qin, H.; Leng, Y.; Li, X.; Zhang, L.; Bai, D.; Meng, Y.; Wang, J. LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF-β1 and VEGF. Exp. Ther. Med. , 2018 , 16 (3), 2337-2342. [http://dx.doi.org/10.3892/etm.2018.6451] [PMID: 30186476] [8] Jaé, N.; Dimmeler, S. Long noncoding RNAs in diabetic retinopathy. Circ. Res. , 2015 , 116 (7), 1104-1106. [http://dx.doi.org/10.1161/CIRCRESAHA.115.306051] [PMID: 25814678] [9] Tong, P.; Peng, Q.H.; Gu, L.M.; Xie, W.W.; Li, W.J. LncRNA-MEG3 alleviates high glucose induced inflammation and apoptosis of retina epithelial cells via regulating miR-34a/SIRT1 axis. Exp. Mol. Pathol. , 2019 , 107 , 102-109. [http://dx.doi.org/10.1016/j.yexmp.2018.12.003] [PMID: 30529346] [10] Thomas, A.A.; Feng, B.; Chakrabarti, S. ANRIL: A regulator of VEGF in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. , 2017 , 58 (1), 470-480. [http://dx.doi.org/10.1167/iovs.16-20569] [PMID: 28122089] [11] Wang, J.; Gao, X.; Liu, J.; Wang, J.; Zhang, Y.; Zhang, T.; Zhang, H. Effect of intravitreal conbercept treatment on the expression of Long Noncoding RNAs and mRNAs in proliferative diabetic retinopathy patients. Acta Ophthalmol. , 2019 , 97 (6), e902-e912. [http://dx.doi.org/10.1111/aos.14083] [PMID: 30900812] [12] Wu, Y.; Jia, K.; Wu, H.; Sang, A.; Wang, L.; Shi, L.; Jiang, K.; Dong, J. A comprehensive competitive endogenous RNA network pinpoints key molecules in diabetic retinopathy. Mol. Med. Rep. , 2019 , 19 (2), 851-860. [http://dx.doi.org/ 10.3892/mmr.2018.9715] [PMID: 30535492] [13] Cao, N.J.; Liu, H.N.; Dong, F.; Wang, W.; Sun, W.; Wang, G. Integrative analysis of competitive endogenous RNA network reveals the regulatory role of non-coding RNAs in high-glucose-induced human retinal endothelial cells. PeerJ , 2020 , 8 , e9452. [http://dx.doi.org/10.7717/peerj.9452] [PMID: 32655995] [14] Luo, R.; Xiao, F.; Wang, P.; Hu, Y.X. lncRNA H19 sponging miR-93 to regulate inflammation in retinal epithelial cells under hyperglycemia via XBP1s. Inflamm. Res. , 2020 , 69 (3), 255-265. [http://dx.doi.org/10.1007/s00011-019-01312-1] [PMID: 31953562] [15] Luo, R.; Jin, H.; Li, L.; Hu, Y.X.; Xiao, F. Long noncoding RNA MEG3 inhibits apoptosis of retinal pigment epithelium cells induced by high glucose via the miR-93/Nrf2 Axis. Am. J. Pathol. , 2020 , 190 (9), 1813-1822. [http://dx.doi.org/10.1016/j.ajpath.2020.05.008] [PMID: 32473920] [16] Fan, G.; Gu, Y.; Zhang, J.; Xin, Y.; Shao, J.; Giampieri, F.; Battino, M. Transthyretin upregulates long non-coding RNA MEG3 by affecting PABPC1 in diabetic retinopathy. Int. J. Mol. Sci. , 2019 , 20 (24), e6313. [http://dx.doi.org/10.3390/ijms20246313] [PMID: 31847264] [17] Yu, X.; Ma, X.; Lin, W.; Xu, Q.; Zhou, H.; Kuang, H. Long noncoding RNA MIAT regulates primary human retinal pericyte pyroptosis by modulating miR-342-3p targeting of CASP1 in diabetic retinopathy. Exp. Eye Res. , 2 -Abstract Truncated-

lncRNA H19 sponging miR-93 to regulate inflammation in retinal epithelial cells under hyperglycemia via XBP1s

Inflammatory Machenism in the Pathogenesis of Diabetic Retinopathy

Long Non-coding RNAs: Pivotal Epigenetic Regulators in Diabetic Retinopathy

lncRNA H19 prevents endothelial–mesenchymal transition in diabetic retinopathy

lncRNA HOTAIR promotes ROS generation and NLRP3 inflammasome activation by inhibiting Nrf2 in diabetic retinopathy

Long Non-Coding RNA XIST Regulates Hyperglycemia-Associated Apoptosis and Migration in Human Retinal Pigment Epithelial Cells.

Long Non-coding RNA H19 Suppression Protects the Endothelium Against Hyperglycemic-Induced Inflammation via Inhibiting Expression of miR-29b Target Gene Vascular Endothelial Growth Factor a Through Activation of the Protein Kinase B/Endothelial Nitric Oxide Synthase Pathway

Activation of the TXNIP/NLRP3 Inflammasome Pathway Contributes to Inflammation in Diabetic Retinopathy: a Novel Inhibitory Effect of Minocycline.

LncRNA MALAT1 aggravates the retinal angiogenesis via miR-320a/HIF-1α axis in diabetic retinopathy

Elevated microRNA‐20b‐3p and reduced thioredoxin‐interacting protein ameliorate diabetic retinopathy progression by suppressing the NLRP3 inflammasomes

LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis

Pharmacological roles of lncRNAs in diabetic retinopathy with a focus on oxidative stress and inflammation

Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy

The exosome-transmitted lncRNA LOC100132249 induces endothelial dysfunction in diabetic retinopathy

RNCR3: A Regulator of Diabetes Mellitus-Related Retinal Microvascular Dysfunction

Microglia-endothelial cross-talk regulates diabetes-induced retinal vascular dysfunction through remodeling inflammatory microenvironment

MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p/XBP1 axis

Functions of Microrna in Pathogenesis of Diabetic Retinopathy

MicroRNA-148a-3p alleviates high glucose-induced diabetic retinopathy by targeting TGFB2 and FGF2

Knockdown of HOTAIR Alleviates High Glucose-Induced Apoptosis and Inflammation in Retinal Pigment Epithelial Cells

Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Diabetic Retinopathy.